FDA rebuffs allegations that it has deprioritized enforcement

FDA is pushing back against assertions made in Science that a decline in the overall number of warning letters during the Trump administration is the result of a politically motivated, deregulatory agenda.

The article states that FDA’s "compliance and enforcement actions have plummeted since President Donald Trump took office.” It reports that the number of warning letters sent by FDA fell by a third from Trump’s inauguration through May 2019 compared with the most recent equivalent period in the Obama administration...